Ams Osram Hit by 15% Two-Day Slide as Broadcom Fallout Deepens Tech Rotation

Ams Osram shares fell over 15% in two sessions after Broadcom’s outlook triggered a tech sell-off, erasing a 137% year-to-date gain despite no negative company news.

The recent rally in Ams Osram shares has been erased with remarkable speed. Over the course of two trading sessions, the stock shed more than 15% of its value, first losing 5.6% on Thursday and then plunging another 10.22% on Friday to close at €20.20. The damage was triggered by a familiar culprit: a sector-wide rotation out of technology names that intensified after Broadcom's disappointing outlook.

What began as a broad shift in investor sentiment on Thursday — when the SMI rose 1.0% while Ams Osram fell and defensives like Novartis and Roche gained 2.0% and 4.2% respectively — turned into a full-blown sell-off the next day. Broadcom shed 12.6% in pre-market trading after its guidance missed expectations, dragging down the entire semiconductor complex. Infineon dropped 6.20%, and Ams Osram found itself the weakest link in the Swiss market. The stock's relative underperformance against a stable SPI index pointed to a targeted rotation out of high-momentum chip names.

The sell-off landed on fertile ground. Ams Osram had run up 137.65% since the start of the year and 49.08% over the past month alone, leaving the stock dangerously exposed to profit-taking. With a 52-week high of €26.70 still 24.34% above Friday's close, the retreat reflects a market that had priced in a great deal of optimism. The 30-day annualised volatility of 122.29% underscores just how jittery trading in the name has become.

Crucially, the company itself has not issued any negative news. The last official guidance, released on 6 May 2026, remains unchanged: second-quarter revenue is expected between €725 million and €825 million, with an adjusted EBITDA margin of approximately 15.5%. For the full year 2026, management guided for free cash flow of more than €300 million, including divestment proceeds and a significant reduction in factoring. A moderate decline in sales and temporary EBITDA pressure are part of the transition plan.

The next event on the calendar is the annual general meeting on 10 June 2026 in Premstätten, where the usual resolutions will be put to a vote. That could refocus attention on the company’s strategic narrative, but whether it will stem the selling pressure depends on whether the broader tech rout subsides in the coming days.

Analyst consensus provides little support at current levels. The average price target stood at €16.42 in May, well below Friday's closing price of €20.20. The range of estimates is wide: JPMorgan had a target of €23.00, while Jefferies and UBS saw fair value between CHF 11.00 and CHF 21.00. After the rally, the stock had overshot even the upper end of that bracket.

Technically, the picture is less clear-cut than the sharp drop suggests. The Relative Strength Index sits at 50.6, squarely in neutral territory. The 50-day moving average of €16.02 and the 200-day line of €11.37 offer two reference points. As long as the stock holds above the former, the decline can be viewed as a severe correction within an ongoing uptrend. A breach below €16.02 would bring the valuation much closer to analyst targets and likely intensify selling pressure.